drugset / Trial / NCT01112072
Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will determine the efficacy of corneal collagen crosslinking (CXL) combined with Intacs for the treatment of keratoconus and corneal ectasia. The goal of CXL is to decrease the progression of keratoconus, while Intacs has been shown to decrease corneal steepness in keratoconus. This study will attempt to determine the relative efficacy of the two procedures either performed at the same session versus CXL performed 3 months after Intacs.
Timeline
- Start
- 2010-04
- Primary completion
- 2024-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Riboflavin | Other / unclassified | — | Topical |